Warning:
This document is being maintained for historical purposes, but is now out of date. To view current guidelines please visit:
- STD Treatment Guidelines at http://www.cdc.gov/STD/treatment
1993 Sexually Transmitted Diseases Treatment Guidelines
09/24/1993 SUGGESTED CITATION Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR 1993;42(No. RR-14): {inclusive page numbers}. CIO Responsible for this publication: National Center for Prevention Services, Division of Sexually Transmitted Diseases and HIV Prevention Sexual Assault or Abuse of Children Recommendations in this report are limited to the identification and treatment of sexually transmitted infections. Management of the psychosocial and legal aspects of the sexual assault or abuse of children are important, but are beyond the scope of these recommendations. The identification of sexually transmissible agents among children beyond the neonatal period suggests sexual abuse. However, there are exceptions; for example, rectal or genital infection with C. trachomatis among young children may be the result of perinatally acquired infection and may persist for as long as 3 years. In addition, BV and genital mycoplasmas have been identified among children who have been abused and among those who have not been abused. A finding of genital warts, although suggestive of assault, is not specific for sexual abuse without other evidence. When the only evidence of sexual abuse is the isolation of an organism or the detection of antibodies to a sexually transmissible agent, findings should be confirmed and the implications carefully considered. Evaluation for Sexually Transmitted Infections Examinations of children for sexual assault or abuse should be conducted so as to minimize trauma to the child. The decision to evaluate the child for STDs must be made on an individual basis. Situations involving a high risk for STDs and a strong indication for testing include the following: -- A suspected offender is known to have an STD or to be at high risk for STDs (e.g., multiple partners or past history of STD), -- The child has symptoms or signs of an STD, -- There is a high STD prevalence in the community. Obtaining the indicated specimens requires skill to avoid psychological and physical trauma to the child. The clinical manifestations of some sexually transmitted infections are different among children when compared with adults. Examinations and specimen collection should be conducted by practitioners who have experience and training in the evaluation of abused or assaulted children. A principal purpose of the examination is to obtain evidence of an infection that is likely to have been sexually transmitted. However, because of the legal and psychosocial consequences of a false-positive diagnosis, only tests with high specificities should be used. Additional cost and time are justified to obtain such tests. The scheduling of examinations should depend on the history of assault or abuse. If initial exposure is recent, infectious agents acquired through the exposure may not have produced sufficient concentrations of organisms to result in positive tests. A follow-up visit approximately 2 weeks after the last sexual exposure should include a repeat physical examination and collection of additional specimens. To allow sufficient time for antibody to develop, another follow-up visit approximately 12 weeks after the last sexual exposure also is necessary to collect sera. A single examination may be sufficient if the child was abused for an extended period of time, or if the last suspected episode of abuse took place some time before the child received the medical evaluation. The following recommendation for scheduling examinations is a general guide. The exact timing and nature of follow-up contacts should be determined on an individual basis and should be considerate of the patient's psychological and social needs. Compliance with follow-up appointments may be improved when law enforcement personnel or child protective services are involved. Initial and 2-Week Examinations During the initial examination and 2-week follow-up examination (if indicated), the following should be performed: -- Cultures for N. gonorrhoeae specimens collected from the pharynx and anus in both sexes, the vagina in girls, and the urethra in boys. Cervical specimens are not recommended for prepubertal girls. For boys, a meatal specimen of urethral discharge is an adequate substitute for an intraurethral swab specimen when discharge is present. Only standard culture systems for the isolation of N. gonorrhoeae should be used. All presumptive isolates of N. gonorrhoeae should be confirmed by at least two tests that involve different principles (e.g., biochemical, enzyme substrate, or serologic methods). Isolates should be preserved in case additional or repeated testing is needed. -- Cultures for C. trachomatis from specimens collected from the anus in both sexes and from the vagina in girls. Limited information suggests that the likelihood of recovering chlamydia from the urethra of prepubertal boys is too low to justify the trauma involved in obtaining an intraurethral specimen. A urethral specimen should be obtained if urethral discharge is present. Pharyngeal specimens for C. trachomatis also are not recommended for either sex because the yield is low, perinatally acquired infection may persist beyond infancy, and culture systems in some laboratories do not distinguish between C. trachomatis and C. pneumoniae. Only standard culture systems for the isolation of C. trachomatis should be used. The isolation of C. trachomatis should be confirmed by microscopic identification of inclusions by staining with fluorescein-conjugated monoclonal antibody specific for C. trachomatis. Isolates should be preserved. Nonculture tests for chlamydia are not sufficiently specific for use in circumstances involving possible child abuse or assault. -- Culture and wet mount of a vaginal swab specimen for T. vaginalis infection. The presence of clue cells in the wet mount suggests BV among children with vaginal discharge. The significance of clue cells or other indicators of BV as an indicator of sexual exposure is unclear. The clinical significance of clue cells or other indicators of BV in the absence of vaginal discharge also is not clear. -- Collection of a serum sample to be preserved for subsequent analysis if follow-up serologic tests are positive. If the last sexual exposure occurred greater than 8 weeks before the initial examination, sera should be tested immediately for antibody to sexually transmitted agents. Agents for which suitable tests are available include T. pallidum, HIV, and HBV. The choice of agents for serologic tests should be made on a case-by-case basis (see Examination 12 Weeks After Assault). Examination 12 Weeks After Assault An examination approximately 12 weeks after the last suspected sexual exposure is recommended to allow time for antibodies to infectious agents to develop. Serologic tests for the agents listed below should be considered: -- T. pallidum, -- HIV, -- HBV. The prevalence of these infections varies greatly among communities, and depends upon whether risk factors are known to be present in the abuser or assailant. Also, results of HBV tests must be interpreted carefully, because HBV may be transmitted by nonsexual modes as well as sexually. The choice of tests must be made on a case-by-case basis. Presumptive Treatment There are few data upon which to establish the risk of a child's acquiring a sexually transmitted infection as a result of sexual abuse. The risk is believed to be low in most circumstances, although documentation to support this position is inadequate. Presumptive treatment for children who have been sexually assaulted or abused is not widely recommended because girls appear to be at lower risk for ascending infection than adolescent or adult women, and regular follow-up can usually be assured. However, some children or their parents or guardians may be very concerned about the possibility of contracting an STD, even if the risk is perceived by the health-care practitioner to be low. Addressing patient concerns may be an appropriate indication for presumptive treatment in some settings. Reporting Every state, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, and American Samoa have laws that require the reporting of child abuse. The exact requirements vary from state to state but, generally, if there is reasonable cause to suspect child abuse, it must be reported. Health-care providers should contact their state or local child protective service agency about child abuse reporting requirements in their areas.
This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.